• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Prothena - Articles and news items

Amyloidosis - Printed Diagnosis with Mint Green Pills, Injections and Syringe

Prothena’s 2016 2nd quarter results support advancement of multiple clinical development programs

Industry news / 3 August 2016 / Prothena Corporation plc

Prothena Corporation plc has reported financial results for the second quarter and first six months of 2016. In addition, the Company provided an update on its R&D programs and 2016 financial guidance…

Prothena initiates NEOD001 global Phase 3 registrational trial

Prothena initiates NEOD001 global Phase 3 registrational trial based on positive results in ongoing phase 1/2 study

Industry news / 3 December 2014 / Prothena

Prothena initiates NEOD001 global Phase 3 registrational trial based on positive results in ongoing phase 1/2 study of NEOD001 in Patients With AL Amyloidosis…

 

Win an Amazon Gift Card worth up to €100!TAKE OUR SURVEY
+ +